RET Fusion
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
RET Fusion
Jul 14, 2024, 06:07 |
Blog
Shahrin Ahmed: The FDA has approved Selpercatinib for treating RET-linked thyroid cancer
Shahrin Ahmed, Medical specialist at Canadian Cancer Society, shared on X: "The FDA has approved Selpercatinib…
Apr 19, 2024, 06:09 |
Blog
Dr. Gilberto Lopes shares about his work in Sylvester Comprehensive Cancer Center
Sylvester Comprehensive Cancer Center shared on LinkedIn: "Gilberto Lopes, associate director of global oncology believes…
Mar 16, 2024, 10:45 |
Drugs
Vivek Subbiah: Exceptional Responses to Selpercatinib in RET Fusion–Driven Metastatic Pancreatic Cancer
Vivek Subbiah recently shared a post on X/Twitter: “Exceptional Responses to Selpercatinib in RET Fusion–Driven…
Dec 4, 2023, 15:54 |
Blog
Vivek Subbiah: Tissue-agnostic precision medicine takes the spotlight!
Vivek Subbiah shared a post on his LinkedIn page: "Hot off the press- Friday Motivation!…
Oct 18, 2023, 17:41 |
Blog
Pashtoon Kasi: Here’s a cool precision medicine story about Liquid Biopsies
Quoting Pashtoon Kasi, oncologist and researcher at Weill Cornell Medicine on X/Twitter: "Here’s a cool…
All:
5
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube